Cargando…

Two cases of multiple-drug-resistant adult-onset Still's disease treated successfully with tocilizumab - the relationship between interleukin 6 and 18

Detalles Bibliográficos
Autores principales:	Sato, Kojiro, Yamamoto, Akinori, Yoshida, Yoshihiro, Mimura, Toshihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332418/ http://dx.doi.org/10.1186/ar3663

Ejemplares similares

18. A case of atypical adult-onset Still’s disease
por: McKnight, Jonathan, et al.
Publicado: (2019)

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
por: Deslypere, G, et al.
Publicado: (2011)

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
por: Alexeeva, E, et al.
Publicado: (2011)

The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma
por: Goran, Ristic, et al.
Publicado: (2011)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
por: Nemiche, O, et al.
Publicado: (2011)

Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab
por: Imaizumi, Chihiro, et al.
Publicado: (2022)

23. Adult-onset Still’s disease presenting as SLE
por: Ellis, Natalya, et al.
Publicado: (2019)

Tocilizumab for the treatment of systemic onset JIA: a single centre experience from India
por: Sawhney, Sujata, et al.
Publicado: (2012)

Therapeutic responses and prognosis in Korean adult-onset Still’s disease
por: Kim, Hyoun-Ah, et al.
Publicado: (2011)

PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan
por: Yokota, S, et al.
Publicado: (2013)

The frequency of MEFV gene variations in Adult-onset Still's disease and Gout
por: Ugurlu, S, et al.
Publicado: (2015)

Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine
por: Ichikawa, Takanori, et al.
Publicado: (2019)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011)

A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2017)

Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A
por: Kawaguchi, Hoshimi, et al.
Publicado: (2017)

Successful Treatment of Recurrent Adult-Onset Still’s Disease with Tocilizumab: A Case Report and Literature Review
por: Zhong, Xiaojing, et al.
Publicado: (2023)

Interleukin-6 receptor in the recent-onset rheumatoid arthritis
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2011)

Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease
por: Brachat, A, et al.
Publicado: (2015)

Simultaneous targeting of interleukin-1 and interleukin-18 is required for protection against inflammatory and septic shock
por: Berghe, T Vanden, et al.
Publicado: (2014)

The Role of Interleukin 18/Interleukin 18-Binding Protein in Adult-Onset Still’s Disease and Systemic Juvenile Idiopathic Arthritis
por: Girard-Guyonvarc’h, Charlotte, et al.
Publicado: (2022)

A Case of Adult-Onset Still’s Disease Caused by a Novel Splicing Mutation in TNFAIP3 Successfully Treated With Tocilizumab
por: Lawless, Dylan, et al.
Publicado: (2018)

A Case Report on Adult-Onset Still’s Disease Successfully Treated With Tocilizumab: A Brief Review on its Safety and Efficacy
por: Nagalli, Shivaraj, et al.
Publicado: (2020)

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
por: De Benedetti, Fabrizio, et al.
Publicado: (2014)

Osteomyelitis due to methicillin-resistant Staphylococcus aureus successfully treated by an oral combination of minocycline and trimethoprim–sulfamethoxazole
por: Sato, Kojiro, et al.
Publicado: (2019)

Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's Disease
por: Drepper, Michael, et al.
Publicado: (2013)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Different Features of Interleukin-37 and Interleukin-18 as Disease Activity Markers of Adult-Onset Still’s Disease
por: Nam, Seoung Wan, et al.
Publicado: (2021)

Increased serum Interleukin-18 in the active phase of Henoch-Schönlein purpura
por: Rigante, Donato, et al.
Publicado: (2011)

PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
por: Sato, T, et al.
Publicado: (2013)

Macrophage activation syndrome in a newborn infant born to a untreated mother with adult onset still disease
por: Rhim, Jung Woo, et al.
Publicado: (2014)

20. A challenging diagnosis of adult-onset Still’s disease in the setting of raised anti-streptolysin O titres
por: Joy, Mareen, et al.
Publicado: (2019)

Myositis as a rare complication after tocilizumab treatment
por: Quesada-Masachs, Estefania, et al.
Publicado: (2014)

Temporal changes of serum cytokine/chemokine levels in patients of Nakajo-Nishimra syndrome treated with tocilizumab
por: Kanazawa, N, et al.
Publicado: (2015)

Interleukin 12 is associated with cerebral atrophy in childhood-onset systemic lupus erythematosus
por: Postal, Mariana, et al.
Publicado: (2014)

Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2018)

Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease: A Case-Based Review
por: Watanabe, Eri, et al.
Publicado: (2016)

Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
por: Miyamae, Takako, et al.
Publicado: (2011)

Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
por: Vargas, Ana Beatriz, et al.
Publicado: (2012)

Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
por: Horneff, G, et al.
Publicado: (2015)

The correlations of serum interleukin-6 (il-6) levels and serum soluble il-6 receptor levels with disease activity in systemic juvenile idiopathic arthritis patients with and without tocilizumab treatment
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d83kidbh0alo6japeucd87kp1l